Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...

September 30, 2026 | Wednesday | News
Sun Nuclear Validates AdaptCHECK for Siemens Healthineers’ Accela Adaptive Radiotherapy System

Sun Nuclear, a Mirion Medical company, announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technica...

September 29, 2026 | Tuesday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News
Accuray and Samsung NeuroLogica Advance Volumetric Imaging for CyberKnife Platform

Accuray Incorporated (NASDAQ: ARAY) announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogi...

September 29, 2026 | Tuesday | News
InnoCare Pharma and Eli Lilly Partner to Develop New Medicines Across Five Targets

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that the Company has entered ...

September 25, 2026 | Friday | News
Sanofi UCB and Opella Join AstraZeneca in Clean Heat Program

Multinational pharmaceutical companies Sanofi, UCB and Opella have joined AstraZeneca as founding members of the Clean Heat Program, an initiative from sup...

September 23, 2026 | Wednesday | News
Sygnature Discovery Formalises X-Chem Collaboration to Expand DNA-Encoded Library Screening

Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), has established a formal collaboration with X-Chem, a data...

September 16, 2026 | Wednesday | News
HCW Biologics Signs Exclusive Distribution Agreement with Akron Biotech for HCW11-006

Agreement includes pre-payment commitments for product sales and distribution of the second-generation multi-cytokine-based HCW11-006 for use as a reagen...

September 10, 2026 | Thursday | News
Aptar Pharma Partners with Aceso Therapeutics to Advance Inhaled ASO for Cystic Fibrosis

-Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a collaboration with Aceso Therapeutics, a...

September 09, 2026 | Wednesday | News
Nanox Expands U.S. Distribution Network Through New England Partnership

Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider Nano-X Imaging Ltd. (“Nanox&rdqu...

September 08, 2026 | Tuesday | News
AtomVie Opens $160 Million Radiopharmaceutical Manufacturing Facility in Ontario

AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, ce...

September 07, 2026 | Monday | News
Ono Pharma Partners With Aitia to Discover New Neurological Disease Targets Using Causal AI

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) announced that it has entered into a drug ...

September 03, 2026 | Thursday | News
BioMed X Relocates Global Headquarters to Heidelberg Innovation Park, Partners With BioLabs

BioMed X, a leading innovation engine for pharma, announced the relocation of its global headquarters to LAB22 at Heidelberg Innovation Park (hip), toget...

September 03, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close